Thompson C - Search Results

1

CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: implication for CD40 ligand antibody therapy.

Sharp C, Thompson C, Samy ET, Noelle R, Tung KS. Sharp C, et al. Among authors: thompson c. J Immunol. 2003 Feb 15;170(4):1667-74. doi: 10.4049/jimmunol.170.4.1667. J Immunol. 2003. PMID: 12574329

2

Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease.

Bagavant H, Thompson C, Ohno K, Setiady Y, Tung KS. Bagavant H, et al. Among authors: thompson c. Int Immunol. 2002 Dec;14(12):1397-406. doi: 10.1093/intimm/dxf105. Int Immunol. 2002. PMID: 12456587

3

Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy.

Alard P, Thompson C, Agersborg SS, Thatte J, Setiady Y, Samy E, Tung KS. Alard P, et al. Among authors: thompson c. J Immunol. 2001 Apr 1;166(7):4363-9. doi: 10.4049/jimmunol.166.7.4363. J Immunol. 2001. PMID: 11254690

4

Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.

Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F. Uhlig HH, et al. Among authors: thompson c. J Immunol. 2006 Nov 1;177(9):5852-60. doi: 10.4049/jimmunol.177.9.5852. J Immunol. 2006. PMID: 17056509 Free PMC article.

5

Gpr83 expression is not required for the maintenance of intestinal immune homeostasis and regulation of T-cell-dependent colitis.

Toms C, Jessup H, Thompson C, Baban D, Davies K, Powrie F. Toms C, et al. Among authors: thompson c. Immunology. 2008 Nov;125(3):302-12. doi: 10.1111/j.1365-2567.2008.02857.x. Epub 2008 May 9. Immunology. 2008. PMID: 18479351 Free PMC article.

6

MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation.

Howie D, Nolan KF, Daley S, Butterfield E, Adams E, Garcia-Rueda H, Thompson C, Saunders NJ, Cobbold SP, Tone Y, Tone M, Waldmann H. Howie D, et al. Among authors: thompson c. J Immunol. 2009 Oct 1;183(7):4197-204. doi: 10.4049/jimmunol.0901070. Epub 2009 Sep 14. J Immunol. 2009. PMID: 19752228

7

OX40 is required for regulatory T cell-mediated control of colitis.

Griseri T, Asquith M, Thompson C, Powrie F. Griseri T, et al. Among authors: thompson c. J Exp Med. 2010 Apr 12;207(4):699-709. doi: 10.1084/jem.20091618. Epub 2010 Apr 5. J Exp Med. 2010. PMID: 20368580 Free PMC article.

8

Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cua DJ, Powrie F. Uhlig HH, et al. Among authors: thompson c. Immunity. 2006 Aug;25(2):309-18. doi: 10.1016/j.immuni.2006.05.017. Immunity. 2006. PMID: 16919486 Free article.

9

Regulatory T cells.

Thompson C, Powrie F. Thompson C, et al. Curr Opin Pharmacol. 2004 Aug;4(4):408-14. doi: 10.1016/j.coph.2004.05.001. Curr Opin Pharmacol. 2004. PMID: 15251137 Review.

10

Cancer Incidence in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) - The Onco-SOL Ancillary Study.

Parada H, Agalliu I, Sotres-Alvarez D, Olshan AF, Evenson KR, Rohan TE, Kaplan RC, Thompson CA, Gallo LC, Penedo FJ, Cai J, Wassertheil-Smoller S, Thyagarajan B, Thomas SN, Garcia-Bedoya OL, Daviglus ML, Talavera GA. Parada H, et al. Among authors: thompson ca. Cancer Epidemiol Biomarkers Prev. 2025 Jan 14. doi: 10.1158/1055-9965.EPI-24-1325. Online ahead of print. Cancer Epidemiol Biomarkers Prev. 2025. PMID: 39808161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,846 results

Search Page

Filters